Lawrence Marnett
-
February 14, 2019
The yin and yang of cell signaling
Larry Marnett and colleagues have explored the role of two enzymes in metabolizing molecules associated with cell proliferation, inflammatory processes and neurological diseases. -
September 6, 2018
Biomedical sciences journey starts from Simple Beginnings
Vanderbilt University School of Medicine welcomed 112 new doctoral students on Aug. 31 during the ninth annual Simple Beginnings ceremony in a Light Hall lecture room filled with family members and other well-wishers. -
August 30, 2018
Energetic gene switch
New findings link flux through glycolysis, which produces cellular energy, with transcription and gene expression via histone modification. -
June 8, 2018
$8.1 million grant funds new center to research highly aggressive form of lung cancer
A five-year National Cancer Institute grant will fund an interdisciplinary research center for the study of small cell lung cancer, a highly aggressive, incurable form of the disease. -
February 22, 2018
Mitochondrial mutations and disease
New findings suggest that oxidative stress damages mitochondrial DNA, and they link this damage to a disease state. -
September 14, 2017
Talking epigenetics
Ian Macara, Ph.D., left, chair of the Department of Cell and Developmental Biology, and Lawrence Marnett, Ph.D., right, dean of Basic Sciences in the School of Medicine, visited with Rockefeller University professor David Allis, Ph.D., last week prior to Allis’ Flexner Discovery Lecture on epigenetics. -
April 13, 2017
Vanderbilt University School of Medicine moves to eighth in NIH research funding
Vanderbilt University School of Medicine (VUSM) now ranks No. 8 in the nation among U.S. medical schools in total grant support provided through the National Institutes of Health (NIH). The new ranking raises VUSM’s standing two spots from the No. 10 position it held last year.